Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance
Open Access
- 16 May 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 66 (4) , 520-525
- https://doi.org/10.1002/(sici)1097-0215(19960516)66:4<520::aid-ijc16>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Expresssion of a 95 kDa membrane protein is associated with low daunorubicin accumulation in leukaemic blast cellsBritish Journal of Cancer, 1995
- A Novel Mutant Topoisomerase II.alpha. Present in VP-16-Resistant Human Melanoma Cell Lines Has a Deletion of Alanine 429Biochemistry, 1994
- Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cellsBiochemical Pharmacology, 1994
- Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase IIJournal of Cellular Physiology, 1993
- Pharmacologic circumvention of multidrug resistanceCytotechnology, 1993
- p-Glycoprotein expression in malignant melanomaZeitschrift für Krebsforschung und Klinische Onkologie, 1991
- Modulators of P-glycoprotein-associated multidrug resistancePublished by Springer Nature ,1991
- Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.Journal of Clinical Oncology, 1989
- Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulationBlood, 1989
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979